mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |